Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
48.4M
-
Shares change
-
+451K
-
Total reported value, excl. options
-
$483M
-
Value change
-
-$577K
-
Number of buys
-
44
-
Number of sells
-
-38
-
Price
-
$9.98
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2021
104 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q4 2021.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.4M shares
of 63.6M outstanding shares and own 76.07% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.26M shares), NEA Management Company, LLC (4.91M shares), RA CAPITAL MANAGEMENT, L.P. (4.87M shares), BAKER BROS. ADVISORS LP (3.86M shares), BlackRock Inc. (3.33M shares), JANUS HENDERSON GROUP PLC (3.13M shares), GOLDMAN SACHS GROUP INC (3.1M shares), FEDERATED HERMES, INC. (2.8M shares), VANGUARD GROUP INC (2.32M shares), and STATE STREET CORP (1.93M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.